Paclitaxel coated balloon - Lutonix/C.R. Bard

Drug Profile

Paclitaxel coated balloon - Lutonix/C.R. Bard

Alternative Names: Lutonix; Lutonix 35 drug coated balloon PTA catheter; Lutonix DCB; Lutonix paclitaxel DCB; Lutonix paclitaxel-coated balloon - Lutonix/CR Bard; Lutonix paclitaxel-coated PTA dilatation catheter; Lutonix® Drug Coated PTA Dilatation Catheter; MD02-LDCB; Paclitaxel-coated percutaneous transluminal angioplasty balloon - Lutonix/CR Bard

Latest Information Update: 04 Sep 2015

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Lutonix
  • Developer CR Bard; Lutonix
  • Class Antineoplastics; Diterpenes; Paclitaxels; Small molecules; Taxanes
  • Mechanism of Action Mitosis inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Marketed Peripheral arterial disorders

Most Recent Events

  • 25 Jun 2015 Updated efficacy results from the Levant 2 phase II trial in Peripheral arterial disorders released by C.R. Bard
  • 23 Oct 2014 Launched for Peripheral arterial disorders in USA (Intra-arterial)
  • 10 Oct 2014 Registered for Peripheral arterial disorders in USA (Intra-arterial)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top